Garay R P, Ciccone J
Biochim Biophys Acta. 1982 Jun 28;688(3):786-92. doi: 10.1016/0005-2736(82)90292-9.
Human erythrocytes are able to incorporate cyclic AMP (cAMP) in amounts larger than those required to saturate cAMP-dependent protein kinase. In contrast to previous observations in avian red blood cells in which cAMP stimulates the Na+/K+ cotransport system, we demonstrate that cAMP inhibits this system in human erythrocytes. The cotransport inhibition is enhanced by addition of phosphodiesterase inhibitor 1-methyl-3-isobutylxanthine to the incubation medium. The cAMP concentration giving half-maximal cotransport inhibition showed a wide variation among different individuals (from 0.1 to 5 mM external cAMP concentration). In contrast to cAMP, cyclic GMP showed little effect on the cotransport system. Ca2+ introduced into the cell interior was an inhibitor of the Na+/K+ cotransport system. These results suggest that in human cells in which endogeneous levels of cAMP and Ca2+ are modulated by hormones, the Na+/K+ cotransport system may be under hormonal regulation.
人类红细胞能够摄取环磷酸腺苷(cAMP),其摄取量大于使依赖cAMP的蛋白激酶饱和所需的量。与先前在鸟类红细胞中观察到的cAMP刺激钠/钾协同转运系统不同,我们证明cAMP在人类红细胞中抑制该系统。向孵育培养基中添加磷酸二酯酶抑制剂1-甲基-3-异丁基黄嘌呤可增强协同转运抑制作用。产生半数最大协同转运抑制作用的cAMP浓度在不同个体间差异很大(细胞外cAMP浓度为0.1至5 mM)。与cAMP相反,环磷酸鸟苷(cGMP)对协同转运系统几乎没有影响。引入细胞内的Ca2+是钠/钾协同转运系统的抑制剂。这些结果表明,在cAMP和Ca2+的内源性水平受激素调节的人类细胞中,钠/钾协同转运系统可能受激素调控。